4
Changes in Ownership
ATOSSA THERAPEUTICS, INC. Filed Acc 0001193125-25-245114
Options or other derivatives
- Chief Financial Officer acquired 578,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Daniel Mark James Chief Financial Officer | 2025-10-14 | Grant or award · Stock Option (right to buy) | +578,000 | 578,000 | D | ||
Loading xslF345X05/ownership.xml…